Shares in Neurocrine Bioscience took a tumble after the company reported mid-stage data for a key pipeline drug for schizophrenia that failed to impress investors. The 19% after-market selloff came ...

While Novo Nordisk delivered strong results for 2025, the market’s negative reaction reflects concerns about the company’s growth trajectory in 2026. The anticipated sales and profit contraction, ...

Good Morning, Asia. Here's what's making news in the markets: Welcome to Asia Morning Briefing, a daily summary of top stories during U.S. hours and an overview of market moves and analysis. For a ...

U.S. equities fell for another session on Thursday as investors took a risk-off stance, leading popular trades in technology and bitcoin to unravel. The Dow Jones Industrial Average shed about 592.58 ...

The Rasmussen Reports daily Presidential Tracking Poll for Friday shows that 45% of Likely U.S. Voters approve of President Trump’s job performance. Fifty-three (53%) disapprove. The latest figures ...

Stock Market Today: Dow closes 670 points lower, S&P 500 logs worst day in 3 weeks as AI fears thrash stocks; Treasury yields drop; gold and silver fall The blue-chip Dow lost it grip on the 50,000 ...